35 related articles for article (PubMed ID: 23277078)
1. Differential association for N-acetyltransferase 2 genotype and phenotype with bladder cancer risk in Chinese population.
Quan L; Chattopadhyay K; Nelson HH; Chan KK; Xiang YB; Zhang W; Wang R; Gao YT; Yuan JM
Oncotarget; 2016 Jun; 7(26):40012-40024. PubMed ID: 27223070
[TBL] [Abstract][Full Text] [Related]
2. Sequence analysis of the N-acetyltransferase 2 gene (NAT2) among Jordanian volunteers.
Jarrar YB; Balasmeh AA; Jarrar W
Libyan J Med; 2018 Dec; 13(1):1408381. PubMed ID: 29173142
[TBL] [Abstract][Full Text] [Related]
3. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.
Rothman N; Garcia-Closas M; Chatterjee N; Malats N; Wu X; Figueroa JD; Real FX; Van Den Berg D; Matullo G; Baris D; Thun M; Kiemeney LA; Vineis P; De Vivo I; Albanes D; Purdue MP; Rafnar T; Hildebrandt MA; Kiltie AE; Cussenot O; Golka K; Kumar R; Taylor JA; Mayordomo JI; Jacobs KB; Kogevinas M; Hutchinson A; Wang Z; Fu YP; Prokunina-Olsson L; Burdett L; Yeager M; Wheeler W; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Johnson A; Schwenn M; Karagas MR; Schned A; Andriole G; Grubb R; Black A; Jacobs EJ; Diver WR; Gapstur SM; Weinstein SJ; Virtamo J; Cortessis VK; Gago-Dominguez M; Pike MC; Stern MC; Yuan JM; Hunter DJ; McGrath M; Dinney CP; Czerniak B; Chen M; Yang H; Vermeulen SH; Aben KK; Witjes JA; Makkinje RR; Sulem P; Besenbacher S; Stefansson K; Riboli E; Brennan P; Panico S; Navarro C; Allen NE; Bueno-de-Mesquita HB; Trichopoulos D; Caporaso N; Landi MT; Canzian F; Ljungberg B; Tjonneland A; Clavel-Chapelon F; Bishop DT; Teo MT; Knowles MA; Guarrera S; Polidoro S; Ricceri F; Sacerdote C; Allione A; Cancel-Tassin G; Selinski S; Hengstler JG; Dietrich H; Fletcher T; Rudnai P; Gurzau E; Koppova K; Bolick SC; Godfrey A; Xu Z; Sanz-Velez JI; D García-Prats M; Sanchez M; Valdivia G; Porru S; Benhamou S; Hoover RN; Fraumeni JF; Silverman DT; Chanock SJ
Nat Genet; 2010 Nov; 42(11):978-84. PubMed ID: 20972438
[TBL] [Abstract][Full Text] [Related]
4. Haplotype-specific PCR for
Wichukchinda N; Pakdee J; Kunhapan P; Imunchot W; Toyo-Oka L; Tokunaga K; Mahasirimongkol S
Hum Genome Var; 2020; 7():13. PubMed ID: 32411379
[TBL] [Abstract][Full Text] [Related]
5. Highlight report: Functional consequences of urinary bladder cancer risk variants.
Selinski S
EXCLI J; 2013; 12():1017-9. PubMed ID: 27034640
[No Abstract] [Full Text] [Related]
6. Impact of urinary bladder cancer risk variants on prognosis and survival.
Selinski S
EXCLI J; 2014; 13():1254-8. PubMed ID: 26417338
[No Abstract] [Full Text] [Related]
7. The post GWAS era: strategies to identify gene-gene and gene-environment interactions in urinary bladder cancer.
Selinski S
EXCLI J; 2014; 13():1198-203. PubMed ID: 26417333
[No Abstract] [Full Text] [Related]
8. Association between N-Acetyltransferase 2 Polymorphism and Bladder Cancer Risk: a Meta-Analysis in a Single Ethnic Group.
Xu WJ; Wen LP; Jiang XX; Ye LY; Meng FH; Guan S; Qian YJ; Wei JF
Clin Lab; 2017 Feb; 63(2):287-293. PubMed ID: 28182356
[TBL] [Abstract][Full Text] [Related]
9. N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk.
Hein DW
Oncogene; 2006 Mar; 25(11):1649-58. PubMed ID: 16550165
[TBL] [Abstract][Full Text] [Related]
10. Clarifying haplotype ambiguity of NAT2 in multi-national cohorts.
Selinski S; Blaszkewicz M; Agundez JA; Martinez C; Garcia-Martin E; Hengstler JG; Golka K
Front Biosci (Schol Ed); 2013 Jan; 5(2):672-84. PubMed ID: 23277078
[TBL] [Abstract][Full Text] [Related]
11. Reconstruction of N-acetyltransferase 2 haplotypes using PHASE.
Golka K; Blaszkewicz M; Samimi M; Bolt HM; Selinski S
Arch Toxicol; 2008 Apr; 82(4):265-70. PubMed ID: 17879084
[TBL] [Abstract][Full Text] [Related]
12. N-acetyltransferase 2 polymorphism and acetylation profiles in Buginese ethnics of Indonesia.
Yuliwulandari R; Susilowati RW; Razari I; Viyati K; Umniyati H; Prayuni K
Ann Hum Genet; 2019 Nov; 83(6):465-471. PubMed ID: 31332782
[TBL] [Abstract][Full Text] [Related]
13. Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk.
Selinski S; Blaszkewicz M; Ickstadt K; Hengstler JG; Golka K
Arch Toxicol; 2013 Dec; 87(12):2129-39. PubMed ID: 24221535
[TBL] [Abstract][Full Text] [Related]
14. Unraveling ambiguous NAT2 genotyping data.
Agúndez JA; Golka K; Martínez C; Selinski S; Blaszkewicz M; García-Martín E
Clin Chem; 2008 Aug; 54(8):1390-4. PubMed ID: 18664443
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism of N-acetyltransferase 2 (NAT2) gene polymorphism in shanghai population: occupational and non-occupational bladder cancer patient groups.
Ma QW; Lin GF; Chen JG; Xiang CQ; Guo WC; Golka K; Shen JH
Biomed Environ Sci; 2004 Sep; 17(3):291-8. PubMed ID: 15602826
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
